Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pannuti

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
European Journal of Cancer & Clinical Oncology|March 1, 1988
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patientsF Pannuti, A Martoni, G Cilenti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Folinic acid plus 5-FU based chemotherapy in squamous cell carcinoma of the head and neck: Bologna experienceF Pannuti, M Guaraldi, A Martoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with 'low' TMX and 'high' MAP dosesC M Camaggi, E Strocchi, N Canova, et al.
Cancer Treatment Reports|April 1, 1978
A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetateF Pannuti, A Martoni, G R Lenaz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
HPLC analysis of doxorubicin, epirubicin and fluorescent metabolites in biological fluidsC M Camaggi, R Comparsi, E Strocchi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1984
A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III studyF Pannuti, G Iafelice, A Martoni, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1991
5-Fluorouracil, epirubicin and cyclophosphamide (FEC combination) in advanced breast cancerC Zamagni, A Martoni, L Ercolino, et al.
Journal of the Royal Society of Medicine|March 13, 1998
Home artificial nutrition in advanced cancerL Pironi, E Ruggeri, S Tanneberger, et al.
The International Journal of Biological Markers|October 1, 1992
CA-549 serum levels in breast cancer monitoringC Zamagni, A Martoni, N Cacciari, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1990
Cisplatinum plus epirubicin alternated with cyclophosphamide plus 5-fluorouracil in ovarian cancerA Martoni, L Ercolino, A Bellucco, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Cancer & Clinical Oncology|March 1, 1988
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patientsF Pannuti, A Martoni, G Cilenti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Folinic acid plus 5-FU based chemotherapy in squamous cell carcinoma of the head and neck: Bologna experienceF Pannuti, M Guaraldi, A Martoni, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with 'low' TMX and 'high' MAP dosesC M Camaggi, E Strocchi, N Canova, et al.
Cancer Treatment Reports|April 1, 1978
A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetateF Pannuti, A Martoni, G R Lenaz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
HPLC analysis of doxorubicin, epirubicin and fluorescent metabolites in biological fluidsC M Camaggi, R Comparsi, E Strocchi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1984
A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III studyF Pannuti, G Iafelice, A Martoni, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1991
5-Fluorouracil, epirubicin and cyclophosphamide (FEC combination) in advanced breast cancerC Zamagni, A Martoni, L Ercolino, et al.
Journal of the Royal Society of Medicine|March 13, 1998
Home artificial nutrition in advanced cancerL Pironi, E Ruggeri, S Tanneberger, et al.
The International Journal of Biological Markers|October 1, 1992
CA-549 serum levels in breast cancer monitoringC Zamagni, A Martoni, N Cacciari, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1990
Cisplatinum plus epirubicin alternated with cyclophosphamide plus 5-fluorouracil in ovarian cancerA Martoni, L Ercolino, A Bellucco, et al.
Pageof 10